TN based cough syrup pharma owner arrested in Chennai

Written By :  Ruchika Sharma
Published On 2025-10-09 09:08 GMT   |   Update On 2025-10-09 09:08 GMT

TN based cough syrup pharma owner arrested in Chennai

Advertisement

ChennaiIn a midnight operation, the Madhya Pradesh police, with the help of Chennai police, has arrested the owner of Tamil Nadu-based Sresan Pharma in connection with an adulterated cough syrup that allegedly led to the deaths of children in multiple states.

He was detained following a midnight operation and taken to Sunguvarchatram police station for an inquiry, a senior police official said.

Advertisement

The cough syrup in question, ‘Coldrif’, was manufactured by his company is attributed to the deaths of children.

According to the police official, the police teams have been searching for G Ranganathan since October 7 after the Madhya Pradesh police team arrived, and he was finally arrested at 1.30 am today. The police also seized some documents from his Kancheepuram factory.

Read also: Toxic syrup tragedy: MP police hunt pharma co owner after child deaths

After being produced in the court here for obtaining the transit remand, he would be taken to Chhindwara, he said, as reported by PTI.

On October 7, the Sriperumbudur Drug Control Inspector had issued a show-cause notice to the pharma company asking it to explain the discrepancies in the quality and labelling of the medicine.

Read also: Toxic Coldrif Fallout: Tamil Nadu Govt Issues Show-Cause Notice to Sresan Pharma, License at Risk

Officials from the TN Directorate of Drugs Control inspected the manufacturing facility and found that the medicines were allegedly stored in “unhygienic conditions” on the corridors, and they noticed certain risk of contamination, he said.

The Tamil Nadu government had sealed the factory after 20 children from Madhya Pradesh died after consuming the “contaminated” cough syrup allegedly made in the unit. The government banned the cough syrup ‘Coldrif’ in the state from October 1 and ordered the removal of stocks of the medicine from the market.

Read also: Sresan Pharma's Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol Detected

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News